PLIN2 (Perilipin 2), also known as adipose differentiation-related protein (ADRP), is a member of the perilipin family of proteins that regulate lipid droplet formation, trafficking, and metabolism. This page provides comprehensive information about PLIN2's structure, function, and critical role in neurodegenerative diseases including Alzheimer's Disease (AD) and Parkinson's Disease (PD).
The PLIN2 gene is located on chromosome 9p22.1 and encodes a protein of 437 amino acids. The gene consists of multiple exons that encode the characteristic lipid droplet-binding domains. PLIN2 lacks the N-terminal domain present in other perilipin family members, which affects its membrane association properties.
- Chromosome: 9
- Band: p22.1
- NCBI Gene ID: 107
- Ensembl ID: ENSG00000147872
- UniProt: Q99541
PLIN2 is a 46 kDa protein that localizes primarily to the surface of lipid droplets. Unlike other perilipins (PLIN1, PLIN3-5), PLIN2 has a unique structure that allows it to regulate lipid storage without direct phosphorylation by protein kinase A (PKA).
¶ Key Domains
- Lipid Droplet-Binding Domain: C-terminal region that anchors the protein to lipid droplet surfaces
- PAT Domain: Conserved region involved in lipid droplet association
- Hydrophobic Regions: Multiple hydrophobic stretches that penetrate the lipid monolayer
PLIN2 plays a crucial role in regulating lipid droplet dynamics:
- Lipid Storage: Promotes triglyceride storage by facilitating lipid droplet formation and preventing lipolysis
- Lipid Mobilization: Inhibits hormone-sensitive lipase (HSL) access to lipid droplets under basal conditions
- Lipid Droplet Trafficking: Coordinates lipid droplet movement and distribution within cells
PLIN2 is widely expressed in tissues with high lipid content:
- Adipose tissue: Major site of expression
- Liver: Hepatocytes show high PLIN2 levels
- Brain: Expressed in astrocytes and neurons, particularly in regions susceptible to neurodegeneration
- Macrophages: Involved in foam cell formation
PLIN2 is significantly upregulated in AD brains and plays multiple roles in AD pathogenesis:
- Amyloid Interaction: PLIN2 colocalizes with amyloid-beta plaques and may influence plaque formation and composition
- Lipid Dysregulation: AD brains show increased lipid accumulation, with PLIN2 mediating this process
- Neuroinflammation: PLIN2 expression in microglia and astrocytes contributes to chronic neuroinflammation
- Mitochondrial Dysfunction: Altered PLIN2 affects mitochondrial lipid metabolism and function
In PD, PLIN2 is implicated through several mechanisms:
- Alpha-Synuclein Aggregation: Lipid droplets decorated with PLIN2 may serve as platforms for alpha-synuclein aggregation
- Oxidative Stress: PLIN2-mediated lipid accumulation increases oxidative stress vulnerability
- Mitochondrial Quality Control: Disrupted lipid droplet function affects mitophagy and mitochondrial dynamics
- Lipid Metabolism: Alterations in PLIN2 affect cellular lipid homeostasis
Recent studies suggest PLIN2 involvement in ALS:
- Altered lipid droplet dynamics in motor neurons
- Interaction with ALS-related proteins such as TARDBP and FUS
PLIN2 interacts with several key proteins involved in neurodegeneration:
| Protein |
Interaction |
Significance |
| Perilipin 1-5 |
Family members |
Coordinate lipid droplet function |
| Hormone-Sensitive Lipase |
Inhibits |
Prevents lipolysis |
| ATGL |
Regulates |
Controls triglyceride breakdown |
| CGI-58 |
Competes |
Regulates lipolysis activation |
| Alpha-synuclein |
May interact |
Potential role in aggregation |
PLIN2 represents a potential therapeutic target for neurodegenerative diseases:
- Lipid Droplet Modulators: Compounds that normalize PLIN2 expression could restore lipid homeostasis
- Anti-inflammatory Agents: Targeting PLIN2-mediated neuroinflammation
- Metabolic Modulators: Improving cellular energy metabolism
- Developing small molecules that modulate PLIN2 function
- Gene therapy approaches to normalize PLIN2 expression
- Biomarker potential for PLIN2 in cerebrospinal fluid
PLIN2 has potential as a biomarker:
- Blood/CSF Levels: Elevated PLIN2 detected in AD and PD patients
- Imaging: PET ligands targeting lipid droplets in development
- Prognostic Value: PLIN2 levels correlate with disease progression
PLIN2 is a critical regulator of lipid droplet function with significant implications for neurodegenerative disease pathogenesis. Its roles in lipid homeostasis, neuroinflammation, and protein aggregation make it an important therapeutic target. Understanding PLIN2 biology provides insights into disease mechanisms and potential treatment strategies.
PLIN2 is conserved across vertebrates, with orthologs in mammals, birds, and fish. The protein's lipid droplet-binding domain shows particularly high conservation, suggesting an ancient role in lipid metabolism.
- *Mouse (Mus musculus)**: Plin2 knockout mice show reduced lipid storage and resistance to diet-induced obesity
- Zebrafish (Danio rerio): Used to study lipid droplet dynamics in vivo
- Drosophila melanogaster: Orthologs (LSD1, LSD2) regulate lipid storage
PLIN2 plays a complex role in autophagy:
- Lipophagy: Selective autophagy of lipid droplets (lipophagy) is regulated by PLIN2
- Autophagosome Formation: PLIN2 recruitment affects autophagosome membranes
- Lysosomal Fusion: Lipid droplet breakdown via lysosomal pathways
PLIN2 intersects with insulin signaling pathways:
- Insulin stimulates PLIN2 phosphorylation
- Affects GLUT4 translocation and glucose uptake
- Contributes to insulin resistance in neurons
Genome-wide association studies have linked PLIN2 variants to:
- Alzheimer's disease risk
- Lipid metabolism traits
- Cardiovascular disease
- Type 2 diabetes
Specific PLIN2 polymorphisms affect:
- Protein expression levels
- Lipid droplet size and number
- Disease susceptibility
PLIN2 as a biomarker:
- Peripheral Biomarker: Blood PLIN2 levels reflect CNS pathology
- Disease Progression: Correlates with cognitive decline in AD
- Treatment Response: May predict therapeutic efficacy
- Fibrates: PPAR agonists reduce PLIN2 expression
- Statins: May affect PLIN2 via cholesterol pathways
- Natural Compounds: Resveratrol, curcumin modulate PLIN2
- CRISPR-based PLIN2 editing
- siRNA-mediated knockdowns
- Viral vector delivery to CNS
- Immunohistochemistry: Antibody-based detection in brain tissue
- Western Blot: Protein level quantification
- Mass Spectrometry: Lipid droplet proteomics
- Live Cell Imaging: Fluorescent protein tagging
- Cell Lines: HeLa, HEK293, neuronal cell lines
- Primary Cultures: Astrocytes, neurons, microglia
- Animal Models: Transgenic and knockout mice
- iPSC-derived: Neurons from patient stem cells
¶ Outstanding Questions
- How does PLIN2 exactly promote neurodegeneration?
- Can PLIN2 modulation slow disease progression?
- What are the cell-type specific roles of PLIN2?
- Single-cell analysis of PLIN2 expression
- Spatial transcriptomics
- Proteomics of lipid droplets
- Cross-disease comparisons (AD, PD, ALS, FTD)
- Chen et al., PLIN2 in metabolic disease (2018)
- Khor et al., Lipid droplets in neurodegeneration (2021)
- Mizuno et al., PLIN2 and mitochondrial function (2020)
- Liu et al., Lipophagy in neuronal cells (2022)
- Tanaka et al., PLIN2 genetic variants and AD risk (2019)
- Kim et al., Therapeutic targeting of lipid droplets (2023)
Last updated: 2026-03-22
| Feature |
PLIN2 |
PLIN1 |
PLIN3 |
| Tissue Expression |
Wide |
Adipose |
Ubiquitous |
| Lipid Droplet Size |
Small |
Large |
Small |
| Regulation |
Constitutive |
Hormonal |
Nutritional |
| Phosphorylation |
No |
Yes |
Limited |
- Regulates lipid droplets in presynaptic terminals
- Affects neurotransmitter vesicle dynamics
- Linked to synaptic plasticity
- Major source of lipid droplets in brain
- Supports neuronal lipid requirements
- Involved in neuroinflammation response
- Lipid accumulation in disease states
- Phagocytic function modulation
- Pro-inflammatory activation
In neurodegeneration, PLIN2-mediated lipid droplet accumulation:
- Compromises Cellular Function: Interferes with organelle function
- Generates Reactive Oxygen Species: Increases oxidative stress
- Promotes Protein Aggregation: Provides scaffold for aggregates
- Disrupts Autophagy: Impairs cellular clearance pathways
PLIN2 affects cellular energetics:
- ATP Production: Altered mitochondrial function
- Metabolic Flexibility: Impaired nutrient sensing
- Calcium Homeostasis: ER stress activation
Currently no direct PLIN2-targeting trials for neurodegeneration. However:
- PPAR agonist trials (affect PLIN2) in AD
- Metabolic modulator studies
- Lipid-lowering agent trials
PLIN2 genetic variants may guide treatment:
- Pharmacogenomic considerations
- Risk stratification
- Preventive strategies
PLIN2 represents a nexus point where lipid metabolism intersects with neurodegeneration. Its dual roles in maintaining lipid homeostasis and promoting pathological lipid accumulation make it a complex but promising therapeutic target. Future research should focus on:
- Developing PLIN2-specific modulators
- Understanding cell-type specific functions
- Identifying downstream effectors
- Validating biomarker utility
Modulation of PLIN2 offers a novel approach to treating neurodegenerative diseases by addressing the fundamental metabolic dysregulation that characterizes these conditions.
- Itabe et al., Perilipin family in disease (2022)
- Kimmel et al., Lipid droplets in cellular stress (2023)
- Zhang et al., PLIN2 in neuroinflammation (2024)